Last update Jan. 17, 2026

Hexavalent Chromium( Cr 6, Cr VI) compounds

Limited compatibility

Unsafe. Moderate/severe adverse effects. Compatible under certain circumstances. Follow-up recommended. Use safer alternative or discontinue breastfeeding from 5 to 7 T ½ . Read Commentary.

Just as trivalent chromium compounds (3+, III) are non-toxic at appropriate doses and constitute an essential nutritional trace element, hexavalent chromium salts (6+, VI: see list of synonyms) have industrial uses (chrome plating, stainless steel), are oxidising, corrosive, irritating, and are classified as carcinogens 1A and mutagens 1B (Wise 2025, Jiang 2025, Guo 2013, Panreac 2011, WHO-OMS 2012, ATSDR 2012, INSHT 2012, 2010 & 2004, Patlolla 2009, IARC 1990), can cause contact dermatitis and severe chronic and acute toxicity (Hald 2009, Lin 2009, André 1998). Chromium 6+ is also found in tobacco smoke (ATSDR 2012), cosmetics (Hepp 2014) and some osteoarticular prostheses. (Oppermann 2015, Nelis 2013)

Due to their hazardous nature, hexavalent chromium compounds currently have no medical uses.

 In terms of occupational risk for breastfeeding mothers (INSHT 2024, EC Regulation 2008), there are only two risk phrases (formerly R phrases, now H phrases for Hazard) or precautionary phrases (P phrases) in a product's safety data sheet that are relevant to breastfeeding:

  • H362 (formerly R64): ‘May cause harm to breastfed children’
  • P263: ‘Avoid contact during pregnancy and breastfeeding’

Six other phrases that should be considered during breastfeeding are related to the carcinogenic, mutagenic or cumulative power of a product:

  • H350 (formerly R45 and R49): ‘May cause cancer.’
  • H351 (formerly R40): ‘Possible carcinogenic effects.’
  • H370 (formerly R39): ‘Causes damage to organs.’
  • H371 (formerly R68): ‘May cause damage to organs.’
  • H372 (formerly R48): ‘Causes damage to organs through prolonged or repeated exposure.’
  • • H373 (formerly R33): ‘May cause damage to organs through prolonged or repeated exposure.’

The Cr(VI) data sheet includes phrases H350 (R45) and H372 (R48) (INSHT 2012, 2010 & 2004, Panreac 2011), which, based on current European regulations (EC Regulation 2008), which states that when a product is carcinogenic and mutagenic, working breastfeeding mothers should not be exposed to mixtures, whether solid, liquid or gaseous, with concentration limits above 0.3%, we consider that breastfeeding mothers should not be exposed to hexavalent chromium compounds in the workplace.

There is no increase in chromium concentrations in milk or problems in infants breastfed by mothers with hip prostheses containing chromium in their composition. (Oppermann 2015, Nelis 2013)


See below the information of this related product:

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Hexavalent Chromium( Cr 6, Cr VI) compounds is also known as


Hexavalent Chromium( Cr 6, Cr VI) compounds in other languages or writings:

  • CrO3 (Molecular formula)

Group

Hexavalent Chromium( Cr 6, Cr VI) compounds belongs to this group or family:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 2 %
Molecular weight 100 daltons
36 hours

References

  1. Jiang Z, Pan M, Liu Y, Lundh T, Pineda D, Schenk L, Saber AT, Vogel U, Ljunggren S, Ricklund N, Engfeldt M, Krais AM, Broberg K; SafeChrom Project Team. Integrative analyses of circulating microRNA expression profile in hexavalent chromium exposed workers - A cross-sectional study within the SafeChrom project. J Hazard Mater. 2025 May 5;488:137367. Abstract Full text (link to original source)
  2. Wise JTF, Chiarugi D, Chi J, Wise JP Sr. Hexavalent chromium exposure impacts the metabolome of human lung fibroblast cells. J Trace Elem Med Biol. 2025 Dec;92:127750. Abstract Full text (link to original source)
  3. INSHT - Instituto Nacional de Seguridad e Higiene en el Trabajo. Límites de exposición profesional para agentes químicos en España. - 2024 Full text (link to original source) Full text (in our servers)
  4. Oppermann M, Borisch C, Schaefer C. Hip arthroplasty with high chromium and cobalt blood levels--Case report of a patient followed during pregnancy and lactation period. Reprod Toxicol. 2015 Abstract
  5. Hepp NM, Mindak WR, Gasper JW, Thompson CB, Barrows JN. Survey of cosmetics for arsenic, cadmium, chromium, cobalt, lead, mercury, and nickel content. J Cosmet Sci. 2014 Abstract
  6. Guo L, Xiao Y, Wang Y. Hexavalent chromium-induced alteration of proteomic landscape in human skin fibroblast cells. J Proteome Res. 2013 Abstract Full text (link to original source)
  7. Goullé JP, Saussereau E, Grosjean J, Doche C, Mahieu L, Thouret JM, Guerbet M, Lacroix C. Accidental potassium dichromate poisoning. Toxicokinetics of chromium by ICP-MS-CRC in biological fluids and in hair. Forensic Sci Int. 2012 Abstract
  8. ATSDR. Chromium. Public Health Statement. 2012 Full text (in our servers)
  9. INSHT. Listado de compuestos Cancerígenos y Mutágenos categorias 1A y 1B. 2012 Full text (in our servers)
  10. ATSDR. Cromo. Resumen de Salud Pública. 2012 Full text (in our servers)
  11. WHO. WHO study group on tobacco product regulation : report on the scientifi c basis of tobacco product regulation: fourth report of a WHO study group. Technical report. 2012 Full text (link to original source) Full text (in our servers)
  12. OMS. Grupo de estudio de la OMS sobre reglamentación de los productos de tabaco: informe sobre la base científica de la reglamentación de los productos de tabaco: cuarto informe de un grupo de estudio de la OMS. Informe técnico. 2012 Full text (link to original source) Full text (in our servers)
  13. Panreac. Cromo Ficha de Datos de Seguridad según Reglamento (CE) 1907/2006. 2011 Full text (in our servers)
  14. INSHT. Regulación UE sobre productos químicos (II). Reglamento CLP: aspectos básicos. None 2010 Full text (in our servers)
  15. Patlolla AK, Barnes C, Hackett D, Tchounwou PB. Potassium dichromate induced cytotoxicity, genotoxicity and oxidative stress in human liver carcinoma (HepG2) cells. Int J Environ Res Public Health. 2009 Abstract Full text (link to original source)
  16. Lin CC, Wu ML, Yang CC, Ger J, Tsai WJ, Deng JF. Acute severe chromium poisoning after dermal exposure to hexavalent chromium. J Chin Med Assoc. 2009 Abstract
  17. Hald M, Agner T, Blands J, Ravn H, Johansen JD. Allergens associated with severe symptoms of hand eczema and a poor prognosis. Contact Dermatitis. 2009 Abstract
  18. - REGULATION (EC) No 1272/2008 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 16 December 2008 on classification, labelling and packaging of substances and mixtures. Official Journal of the European Union. 2008 Full text (link to original source)
  19. Comisión Europea. REGLAMENTO (CE) No 1272/2008 DEL PARLAMENTO EUROPEO Y DEL CONSEJO de 16 de diciembre de 2008 sobre clasificación, etiquetado y envasado de sustancias y mezclas. Diario oficial de la Unión Europea. 2008 Full text (link to original source) Full text (in our servers)
  20. INSHT. Cromo. Fichas Internacionales de Seguridad Química. 2004 Full text (in our servers)
  21. Mukherjee AB. Chromium in the environment of Finland. Sci Total Environ. 1998 Abstract
  22. André N, Paut O, Arditti J, Fabre P, Bremond V, Alhmana T, Bellus JF, Jouglard J, Camboulives J. [Severe potassium dichromate poisoning after accidental nasal introduction]. Arch Pediatr. 1998 Abstract
  23. Paustenbach DJ, Hays SM, Brien BA, Dodge DG, Kerger BD. Observation of steady state in blood and urine following human ingestion of hexavalent chromium in drinking water. J Toxicol Environ Health. 1996 Abstract
  24. IARC - WHO. International Agency for research on Cancer. Chromium, Nickel and Welding. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 49. 1990 Abstract Full text (link to original source)
  25. Baranowska-Dutkiewicz B. Absorption of hexavalent chromium by skin in man. Arch Toxicol. 1981 Abstract

Total visits

10,783

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by AELAMA of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM